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Abstract 
 
Background: Dengue is considered as an important arboviral disease. Safe, low-cost, and effective drugs that possess 
inhibitory activity against dengue virus (DENV) are mostly needed to try to combat the dengue infection worldwide. 
Medicinal plants have been considered as an important alternative to manage several diseases, such as dengue. As 
authors have demonstrated the antiviral effect of medicinal plants against DENV, the aim of this study was to review 
systematically the published research concerning the use of medicinal plants in the management of dengue using the 
PubMed database.  
Materials and Methods: Search and selection of publications were made using the PubMed database following the 
guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA statement).  
Results: Six publications met the inclusion criteria and were included in the final selection after thorough analysis.  
Conclusion: It is suggested that medicinal plants’ products could be used as potential anti-DENV agents. 
 
Keywords: Dengue, arbovirus, medicinal plants, PubMed 
 
Introduction 
 
Dengue, chikungunya and zika are mosquito-borne arboviral diseases (Gubler, 2002). Dengue is considered 
one of the most important of these diseases (Gubler, 2002; Voge et al., 2013 WHO, 2016). Dengue is transmitted by the 
bite of the Aedes aegypti mosquito infected with one of the four dengue virus (DENV 1 - 4) serotypes 
(genus Flavivirus, family Flaviviridae) (Voge et al., 2013; Halstead, 2007; Gubler, 2002; Guzman and Isturiz, 2010; 
WHO, 2016). Infection with one DENV serotype produces only specific antibody against that serotype. When antibody 
from the first infection is neutralized, secondary infections by other serotypes can cause more serious infection 
(Leardkamolkarn et al., 2012). Although DENV-2 is known to be more lethal than other serotypes (Goel et al., 2004), 
some studies have revealed that primary infection with DENV-1 or DENV-3 always results in more dangerous disease 
than infection with the other serotypes (Guzman and Isturiz, 2010; Tang et al., 2012).  
 Dengue epidemic has become an important focus of international public health awareness. It is found mainly 
in tropical and sub-tropical regions of the world, mostly in urban and semi-urban areas (Gubler, 2002; Ahmad et al., 
2011). This has made the epidemic difficult to control due to highly populated areas in cities (Abd Kadir et al., 2013).  
 According to World Health Organization (WHO), dengue is a febrile illness that affects infants, children and 
adults. The symptoms could appear from 3 up to 14 days after the infective bite. It is not transmitted directly from 
person-to-person and symptoms range from mild fever, to incapacitating high fever, with severe headache, pain behind 
the eyes, muscle and joint pain, and rash. There are currently no WHO recommendations for use of a dengue vaccine or 
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any specific medicine to treat dengue. People who have dengue fever should rest, drink plenty of fluids and reduce the 
fever using paracetamol under medical assistance (WHO, 2016). 
 Safe, low-cost, and effective drugs that possess inhibitory activity against DENV are mostly needed to try to 
combat the dengue infection worldwide, especially in the most affected countries, which, in general, have limited 
resources (Goel et al., 2004; Klawikkan et al., 2011; Rothan et al., 2014). Natural products have been considered as an 
important alternative to manage several diseases, such as dengue (Rothan et al, 2014; Lee et al., 2013). 
 A medicinal plant, as a natural product, has been used to traditional healing (Okonkwo, 2012), and as 
treatment sources for various diseases (Orekhov and Ivanova, 2016; Agnaniet et al., 2016), due to their complex 
bioactive ingredients and rich source of pharmaceuticals (Hao et al., 2015; Tadtong et al., 2015). Similarly, many 
extracts and compounds obtained from medicinal plant with antiviral activity have been reported (Kitazato et al., 2007; 
Rebensburg et al., 2016; Wang et al., 2016). Moreover, in general and in comparison, to the synthetic drugs, natural 
products are less toxic and inexpensive (Babar et al., 2013).  
 As authors have demonstrated the antiviral effect of medicinal plants against DENV (Tang et al., 2012; Lee et 
al., 2013; Rothan et al, 2014), the aim of this study was to review systematically the published research concerning the 
use of medicinal plants in the management of dengue using the PubMed database. Considering the findings described 
in the literature, it is hypothesized an antiviral activity against DENV of some medicinal plants. 
  
Materials and Methods 
Search Strategy and Selection of the Studies 
 
Systematic review of scientific studies, following guidelines of the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA statement), was carried out. The PubMed database 
(http://www.ncbi.nlm.nih.gov/pubmed) was systematically searched for experimental trials. The papers were searched 
on July 19th, 2016. The search was performed using the keywords (i) chikungunya, (ii) dengue, (iii) zika, (iv) 
“medicinal plants” and (v) “medicinal plants” and dengue. 
Inclusion and exclusion criteria  
A systematic selection of the publications was carried based on the following inclusion and exclusion criteria, 
as it is shown in the Table 1. 
 
Table 1- Exclusion and Inclusion criteria to select the articles 
Criteria Inclusion Exclusion 
Biological activity Antiviral activity against DENV Another approach 
Study design Experimental trials in vitro 
and/or in vivo (with medicinal 
plants) 
Ethnobotanical and 
ethnopharmacological surveys, 
case reports, expert opinion or 
consensus statements 
Language Articles written in English Articles written in a language 
different of English 
 
Results  
 
 Table 2 shows the number of publications found in the PubMed database involving the keywords that were 
searched. It is possible to verify a strong interest in studies involving "medicinal plants" with almost fifty-nine thousand 
papers, and about 0.040% of these articles are related to dengue. In addition, dengue has more publications than 
chikungunya and zika. Although, the number of publications with zika is the lowest in comparison with dengue and 
chikungunya, it is noted that 987 (87%) of the 1,134 publications with zika are in the last five years. 
Table 2. Number of publications comprising medicinal plants and arboviral diseases transmitted by Aedes aegypti 
mosquito (based on PubMed database). 
Keyword Number of publication 
Chikungunya 2,914 
Dengue 15,745 
“Medicinal plants” 58,894 
“Medicinal plants” AND dengue 24 
Zika 1,134 
                  
According to the search strategy involving the keyword “medicinal plants” AND dengue yielded twenty-four 
articles. Six publications met the inclusion criteria and were select for the final review (Figure 1). 
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Figure 1: Fluxogram of the search strategy comprising the identification of potentially relevant articles, preliminary 
screening and final selection of the studies included in this current review (based on PRISMA statements). 
 
It is possible to see in Table 3 information about the species of plants with anti-viral activity, the DENV 
serotypes and the countries were the studies were performed.  There is a predominance of trials with DENV-2 more 
than with the other serotypes. The species of the medicinal plants used in the studies varied among the selected 
investigations, and in one of the papers (Gabrielsen et al., 1992), isoquinoline alkaloids were used. A great variety of 
species Phyllanthus was utilized (Lee et al, 2013). Furthermore, 50% of the studies were performed in Malaysia.   
 
Table 3: Information about the species of plant, the DENV serotypes and the countries where the selected studies were 
performed. 
Reference Species of plant DENV 
serotypes  
Country 
Rothan et al, 
2014 
 
Vernonia cinerea, Hemigraphis reptans, Hedyotis auricularia, Laurentia 
longiflora, Tridax procumbers and Senna angustifolia. 
DENV-2 Malaysia 
Lee et al., 
2013 
 
Phyllanthus amarus, Phyllanthus niruri, Phyllanthus urinaria, and 
Phyllanthus watsonii. 
DENV-2 Malaysia 
Tang et al., 
2012 
Andrographis paniculata, Ocimum sanctum, Pelargonium citrosum, 
Cymbopogon citratus, Citrus limon and Momordica charantia. 
DENV-1 Malaysia 
Records excluded 
- Without antiviral activity - 
(n=15) 
- Review - (n=1)  
  
Full-text articles 
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Garcia et al., 
2010 
 
Lepechinia floribunda, Cleome aculeata, Eupatorium arnottianum, 
Eupatorium catarium, Lantana grisebachii, Trixis divaricata and 
Lantana camara.  
DENV-2 Argentina 
Garcia et al., 
2003 
 
Aloysia gratissima, Artemisia douglasiana, Eupatorium patens, 
Heterotheca latifolia, Hyptis mutabilis, Lippia junelliana, Lippia 
turbinate and Tessaria absinthioides. 
DENV-2 Argentina 
Gabrielsen et 
al., 1992  
23 Amaryllidaceae isoquinoline alkaloids DENV-4 USA 
DENV- dengue virus 
 
 In the Table 4 are shown the aim, chemical/compounds related to the medicinal plants, results and conclusion 
of the findings reported on the selected studies. The aim of the selected papers was mainly identify the anti-DENV 
effect of medicinal plants. Several chemicals/compounds were used in the investigations, as β-caryophyllene, 
spathulenol and borneol. Despite the different protocols and procedures, the results indicated an inhibitory action 
against the DENV due the action of the medicinal plants. Methanolic extracts were used in three (Rothan et al., 2014; 
Lee et al., 2013; Tang et al., 2012) of the six publications selected. According to the studies, it was concluded that these 
medicinal plants could be used as a potentially anti-DENV agent. 
 
Table 4. Aim, chemicals/compounds and results of findings reported on the selected studies 
Reference Aim Chemicals/Compounds Results 
Rothan et 
al, 2014 
To identify anti-dengue 
activities of medicinal 
plants extracts that are 
used in traditional 
medicine. 
General ME  The highest inhibitory activities against 
dengue NS2B-NS3pro was observed in 
ethanolic extract of SA leaves, ME of 
VC leaves and ethanol extract of TP 
stems. These findings were further 
verified by in vitro viral inhibition 
assay. ME of VC leaves, ethanol extract 
of TP stems and at less extent ethanolic 
extract of SA leaves were able to 
maintain the normal morphology of 
DENV-2-infected Vero cells without 
causing much CPE. The percentage of 
viral inhibition of VC and TP extracts 
were higher than SA extract as 
measured by plaque formation assay 
and RT-qPCR. 
Lee et al., 
2013 
To evaluate the 
possibility of 
developing a local 
medicinal plant, 
Phyllanthus as an anti-
dengue agent. 
Active compounds including gallic acid, 
galloylglucopyronside, corilagen, 
geraniin, rutin, quercetin glucoside, 
syringing, syringing diamer, 
digalloylglucopyronside, 
trigalloylglucopyronside, apigenin 
rhamnoside, and quercetin rhamnoside 
have been identified. 
The MNTD of both aqueous and ME on 
Vero cells were 250.0 and 15.63μg/ml 
respectively. Phyllanthus showed 
strongest inhibitory activity against 
DENV-2 with more than 90% of virus 
reduction in simultaneous treatment. 
Two-dimensional analysis revealed 
altered levels of thirteen proteins, which 
were identified by tandem MS 
(MS/MS). The altered proteins were 
involved in biological processes, as 
viral entry, viral transcription and 
translation regulations, cytoskeletal 
assembly, and cellular metabolism. 
Tang et al., 
2012 
To investigate the 
antiviral effects of 
standardized ME of 
AP, CL, CC, MC, OS 
and PC on DENV-1. 
OS contained 88.6% of total flavonoids 
content, an amount that was the highest 
among all the six plants tested while the 
least was detected in MC. 
The MNTD of the 6 medicinal plants 
was determined with ME against Vero 
E6 cells in vitro. The MNTD was in the 
decreasing order of MC > CL > PC, OS 
> AP > CC. Antiviral assay based on 
CPE denoted by degree of inhibition 
upon treating DENV-1-infected Vero 
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E6 cells with MNTD of 6 medicinal 
plants showed that AP has the most 
antiviral inhibitory effects followed by 
MC. These results were verified with an 
in vitro inhibition assay using MTT, in 
which 113.0% and 98.0% of cell 
viability were recorded as opposed to 
44.6% in DENV-1 infected cells. 
Although ME of OS and CC showed 
slight inhibition effect based on CPE, 
an inhibition was not reflected in MTT 
assay. ME of CL and PC did not 
prevent CPE or cell death from DENV-
1. 
Garcia et 
al., 2010  
To screen for 
cytotoxicity and in 
vitro inhibitory activity 
against HSV-1, DENV-
2 and JUNV. 
LF (1,8-Cineole, guaiol, β-caryophyllene, 
camphor, camphene, borneol and 
aromadendrene). CA (Cadinol-epi-alpha, 
germacrene-D, spathulenol δ-cadinene, 
presilphiperfolan-1-ol, α-muurolene, 
bicyclogermacrene and β–
caryophyllene). LG (bicyclogermacrene, 
germecrene-D, spathulenol, β-
caryophyllene, piperitenone, α–copaene). 
LC (spathulenol, bicyclogermacrene, β-
caryophyllene, α-humulene, humulene-
epoxide II and phytol). EC (limonene, 
piperitenone, trans-dihydrocarvone, 
camphor, cis-dihydrocarvone, β-
caryophyllene and bicyclogermacrene). 
EA (spathulenol, β-caryophyllene, 
germacrene-D bicyclogermacrene α-
humulene, γ-muurolene, α-cadinol, cis-
Cadin-4-en-7-ol, and caryophyllene 
oxide). Trixis divaricata (β–
caryophyllene, spathulenol, β-elemene 
and caryophyllene oxide). 
The oils showed a variable virucidal 
action according to the virus. JUNV 
was the least susceptible virus in 
comparison with HSV-1 and DENV-2. 
The better relationship between 
cytotoxicity and inhibitory activity was 
observed for the essential oil of LG 
against DENV-2 and HSV-1 with IC50 
values of 21.1 and 26.1 ppm, 
respectively. This effect was specific 
since the selectivity indices (ratio 
cytotoxicity/virucidal activity) were > 
23.7 and > 19.1 for DENV-2 and HSV-
1, respectively. The oil from LG was 
also an effective inhibitor of HSV-2 and 
acyclovir resistant variants of HSV. 
Garcia et 
al., 2003 
To screen for virucidal 
activity against HSV-1, 
JUNV and DEN-2. 
AG: caryophyllene oxide; cadinol; 
chrysanthenyl acetate; limonene oxide;β-
caryophyllene. AD: α-thujone; β-thujone; 
borneol; p-cymene; 1.8-cineole; 
isocaryophylene-epoxide. EP: D-
germacrene; β-caryophyllene; 
bicyclogermacrene;α-pinene; 
caryophyllene oxide. HL: borneol; 
camphor; limonene; β-pinene. HM: β-
caryophyllene; germacrene D; curzerene; 
bicyclogermacrene. 
LJ: piperitenone oxide; limonene; 
camphor; spathulenol. LT: limonene; 
piperitenone oxide; β-caryophyllene. TA: 
caryophyllene oxide; (E)-β-damacenone; 
γ-eudesmol; α-gurjunene; terpinen-4ol. 
The most potent inhibition was 
observed with the essential oil of LJ and 
LT against JUNV with VC50 values in 
the range 14–20 ppm, whereas AG, HL 
and TA inhibited JUNV in the range 
52–90 ppm. Virucidal activity was 
time-and-temperature-dependent. 
Essential oils of AG, AD, EP and TA 
inactivated HSV-1 at 65–125 ppm. 
Only AD and EP had any discernible 
effect on DENV-2 infectivity with 
VC50 values of 60 and 150 ppm, 
respectively. 
Gabrielsen 
et al., 1992  
To evaluate the effect 
of 23 Amaryllidaceae 
isoquinoline alkaloids 
and related synthetic 
analogues isolated or 
synthesized and 
Amaryllidaceae isoquinoline alkaloids 
and related synthetic analogues isolated 
or synthesized 
Activity against SF virus was only 
observed with 7deoxy analogues. In 
most cases, selectivity of the active 
compounds was low, with toxicity in 
uninfected cells (TC50) within 10- fold 
that of the viral IC50. No activity was 
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subsequently in cell 
culture against the 
RNA-containing 
flaviviruses.  
 
observed against HIV-1, VEEV, or 
vaccinia viruses. PN and its 7deoxy 
analogue were evaluated in JE mouse 
models (differing in viral dose 
challenge, among other factors). In 
experiments (low LD, viral challenge, 
variant I), prophylactic administration 
of PN at 4 and 6 mg/kg/ day (2% 
EtOH/saline, sc, once daily for 7 days) 
increased survival of JE-virus-infected 
mice. Prophylactic administration of 5 
at 40 mg/kg/day in 
hydroxypropylcellulose (sc, once daily 
for 7 days) increased survival of JE-
virus-infected mice. With high LD, 
viral challenge, administration of 4 at 6 
mg/kg/day (ip, twice daily for 9 days) 
resulted in a 50% survival rate. PN and 
7deoxy-PN demonstrated activity in 
mice infected with JE virus at near toxic 
concentrations. 
PN-Pancratistatin, ME-methanolic extracts, SA-Senna angustifolia, VC-Vernonia cinerea, TP-Tridax procumbers, AP-
Andrographis paniculata, CL- Citrus limon, CC- Cymbopogon citrates, MC - Momordica charantia, OS - Ocimum 
sanctum, PC - Pelargonium citrosum, LF-Lepechinia floribunda, CA-Cleome aculeata, LG-Lantana grisebachii, LC-
Lantana camara, EC-Eupatorium catarium, EA-Eupatorium arnottianum, AG-Aloysia gratissima, AD-Artemisia 
douglasiana, EP-Eupatorium patens, HL-Heterotheca latifolia, HM-Hyptis mutabilis, LJ-Lippia junelliana, LT-Lippia 
turbinate, TA-Tessaria absinthioides DENV – dengue virus; CPE - cytopathic effects, RTq-PCR - real time 
quantitative PCR, MNTD - maximum non-toxic dose, VC50 - virucidal concentration 50%, JUNV – junin virus; HSV 
– herpes simplex virus, MS- mass spectrometry, IC50 - inhibitory concentration 50%, HIV- human immunodeficiency 
virus, JE - japanese encephalitis, LD –letal dose, YF - yellow fever; PT - punta toro; SF -  sandfly fever-Sicilian;  RVF 
- rift valley fever, VEEV - Venezuelan equine encephalomyelitis virus  
 
Discussion 
 
 Investigations about dengue have relevance because it is the fastest spreading vector-borne viral disease, and it 
is endemic in over 100 countries. It is reported that 40% of the world’s population live in areas at risk for dengue 
(WHO, 2016). These reasons justify the increase of publications in PubMed with the arboviral diseases (dengue, 
chikungunya and zika virus) transmitted by Aedes aegypti mosquito (Table 2), mainly in the last years (2012 up to 
2016).  
Development of a safe, low-cost and effective dengue vaccine is a high priority, especially in the most affected 
countries (Goel et al., 2006; Klawikkan et al., 2011; Rothan et al., 2014). Six studies have reached the inclusion criteria 
to be analyzed (Figure 1). The relevance of the medicinal plants in the management of diseases reveals the importance 
of the investigations about their effects in DENV. There are a variety of medicinal plants utilized in the treatment of 
dengue (Table 3), however, only 0.040% of the articles with the keyword “medicinal plants” are related to dengue 
(Table 2). An interesting finding is related to the country where the investigations were performed. Fifty percent of the 
studies was carried out in Malaysia. This fact could be associated with the fact that all the 4 DENV genotypes are 
thought to have independently evolved from a sylvatic ancestral lineage, perhaps in Malaysia (Wang et al., 2000). 
Moreover, Teoh et al., 2010 reported that an ancestral sylvatic DENV-1, which was isolated from a monkey in 1972, it 
was present in a patient with dengue in Malaysia.  
As shown in Table 3, serotype DENV-2 is most studied, perhaps because is known to be more lethal than other 
serotypes (Goel et al., 2004). No study in the PubMed database involving medicinal plants and dengue about the 
DENV-3 was found, although some authors consider that it with the DENV-1 in primary infection always results in 
more dangerous disease than infection with the others serotypes (Guzman and Isturiz, 2010; Tang et al., 2012). 
In all these investigations, an antiviral effect against DENV was detected (table 3). Rothan et al, 2014 have 
verified that methanolic extract of Vernonia cinerea leaves and ethanol extract of Tridax procumbers stems possessed 
high inhibitory activates against DENV. Lee et al., 2013 have described that Phyllanthus could be potentially 
developed as an anti-DENV agent. Jung et al., 2015 also reported that Phyllanthus urinaria extract inhibited hepatitis B 
virus (HBV) DNA synthesis and surface antigen (HBsAg) and core antigen (HBcAg) secretion by replicating cells 
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harboring HBV wild-type and lamivudine (LMV)-resistant mutants, likely by inducing the expression of interferon-
beta (IFN-β), cyclooxygenase-2 (COX-2), and interleukin-6 (IL-6). Tang et al., 2012 have verified that the methanol 
extracts of Andrographis paniculata and Momordica charantia possess the ability of inhibiting the activity of DENV-1 
in in vitro assays. Cai et al, 2015 have also described that Andrographis paniculata, exerted potent anti-influenza A 
virus activity against A/chicken/Hubei/327/2004 (H5N1), A/duck/Hubei/XN/2007 (H5N1), A/PR/8/34 (H1N1), 
A/NanChang/08/2010 (H1N1) and A/HuNan/01/2014 (H3N2) in vitro. Garcia et al., 2010 demonstrate the effective 
and selective inhibitory activity of the essential oil from Lantana grisebachii against HSV and DENV by direct virus 
inactivation. Garcia et al., 2003 support the potential use of essential oils in toto from medicinal plants as agents against 
viral infections. Gabrielsen et al., 1992 reported that Amaryllidaceae alkaloids related to narciclasine and lycorine 
possess antiviral activity with accompanying low selectivity in vitro against three flaviviruses, JE, YF, and DENV; 
against the bunyaviruses, PT and RVF viruses; and, to a lesser extent, against SF virus.  
The current study has several limitations that must be considered in the interpretation of the findings in this 
review. It is suggested caution in generalizing these findings due to the final select publications have methodological 
variations concerning to the experimental procedure and study design utilized. Furthermore, although we have tried to 
retrieve the articles following the selected keywords, it was not retrieved all the papers identified for inclusion, 
including articles that were not published in English, as well, those that are not indexed in the PubMed database. 
Considering the findings described in this study, it is possible to conclude that medicinal plants’ products 
could be used for the development of potential anti-DENV agents. However, it is important to consider the small 
number of publications available in the PubMed database involving searches evaluating the anti-DENV effect of 
medicinal plants. 
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